At-Home Drug of Abuse Testing Market Size & Share Report, 2032

At-home Drug of Abuse (DOA) Testing Market Size - By Type (Test Cups, Test Strips), By Sample Type (Saliva, Urine, Blood) & Global Forecast 2023 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; workings

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data Sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

1.4.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.4.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global at-home drug of abuse (DOA) testing market 360&deg; synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Regional trends

2.3&nbsp;&nbsp;&nbsp; Type trends

2.4&nbsp;&nbsp;&nbsp; Sample type trends

Chapter 3&nbsp;&nbsp;&nbsp;At-home Drug of Abuse (DOA) Testing Industry Insights

3.1&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.2&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.3&nbsp;&nbsp;&nbsp; Technology landscape

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Industry impact forces

3.5.1&nbsp;&nbsp;&nbsp; Growth drivers

3.5.1.1&nbsp;&nbsp;&nbsp;Rise in the production of illicit drugs

3.5.1.2&nbsp;&nbsp;&nbsp;Growing government initiatives to curb drug abuse

3.5.1.3&nbsp;&nbsp;&nbsp;Surge in access to drugs

3.5.1.4&nbsp;&nbsp;&nbsp;Technological advancements and product portfolio expansion

3.5.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.5.2.1&nbsp;&nbsp;&nbsp;Inability of testing products to detect small amounts of special drugs

3.5.2.2&nbsp;&nbsp;&nbsp;Lack of awareness regarding drug testing

3.6&nbsp;&nbsp;&nbsp; Growth potential analysis

3.6.1&nbsp;&nbsp;&nbsp; By type

3.6.2&nbsp;&nbsp;&nbsp; By sample type

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.2.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

4.2.2&nbsp;&nbsp;&nbsp; Dragerwerk AG &amp; Co. KGaA

4.2.3&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche AG

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.4&nbsp;&nbsp;&nbsp; Strategic outlook matrix, 2022

Chapter 5&nbsp;&nbsp;&nbsp;At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Type (Revenue and Volume)

5.1&nbsp;&nbsp;&nbsp; Key trends, by type

5.2&nbsp;&nbsp;&nbsp; Test cups

5.3&nbsp;&nbsp;&nbsp; Test strips

5.4&nbsp;&nbsp;&nbsp; Others

Chapter 6&nbsp;&nbsp;&nbsp;At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Sample Type (Revenue)

6.1&nbsp;&nbsp;&nbsp; Key trends, by sample type

6.2&nbsp;&nbsp;&nbsp; Saliva

6.3&nbsp;&nbsp;&nbsp; Urine

6.4&nbsp;&nbsp;&nbsp; Blood

6.5&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Region (Revenue and Volume)

7.1&nbsp;&nbsp;&nbsp; Key trends, by region

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Italy

7.3.5&nbsp;&nbsp;&nbsp; Spain

7.3.6&nbsp;&nbsp;&nbsp; Switzerland

7.3.7&nbsp;&nbsp;&nbsp; The Netherlands

7.3.8&nbsp;&nbsp;&nbsp; Denmark

7.3.9&nbsp;&nbsp;&nbsp; Poland

7.3.10&nbsp;&nbsp;&nbsp; Sweden

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; New Zealand

7.4.7&nbsp;&nbsp;&nbsp; Thailand

7.4.8&nbsp;&nbsp;&nbsp; Vietnam

7.4.9&nbsp;&nbsp;&nbsp; Indonesia

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Colombia

7.5.5&nbsp;&nbsp;&nbsp; Chile

7.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

7.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.2&nbsp;&nbsp;&nbsp; South Africa

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Turkey

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.2&nbsp;&nbsp;&nbsp; Dragerwerk AG &amp; Co. KGaA

8.3&nbsp;&nbsp;&nbsp; Assure Tech.(Hangzhou) Co., LTD

8.4&nbsp;&nbsp;&nbsp; Atlas Medical GmbH

8.5&nbsp;&nbsp;&nbsp; Confirm BioSciences

8.6&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche AG

8.7&nbsp;&nbsp;&nbsp; Siemens Healthineers AG

8.8&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific, Inc.

8.9&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc.

8.10&nbsp;&nbsp;&nbsp; bioM&eacute;rieux SA

8.11&nbsp;&nbsp;&nbsp; Psychemedics Corporation

8.12&nbsp;&nbsp;&nbsp; OraSure Technologies, Inc.

&nbsp;&nbsp;&nbsp;

Athome Drug of Abuse DOA Testing Market

Get a free sample of this report